zolmitriptan transdermal (Pending FDA Approval)

Brand and Other Names:Qtrypta
  • Print
Sections

Dosing & Uses

Migraine

Microneedle transdermal system pending FDA approval for treatment of migraine headache

Next:

Pharmacology

Mechanism of Action

Selective 5-HT1 receptor agonist in cranial arteries; causes vasoconstriction and reduces inflammation associated with antidromic neuronal nerve fiber transmission

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.